Brain scan study for tau in neurodegenerative diseases
Part of Brain & nervous system clinical trials.
This study uses a special PET/CT brain scan to look at a protein called tau in people with memory/thinking and movement disorders. The results may help researchers understand how these diseases affect the brain and improve future diagnosis or care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 or older
- You have been diagnosed with a listed condition (such as Alzheimer’s, Parkinson’s, ALS, or several frontotemporal or related disorders)
- You (or your legal representative) can provide informed consent, and you agree to the study if possible
- You can attend all scheduled visits and complete the PET/CT imaging
- You are enrolled at the same time in the UNICORN protocol (842873)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special imaging agent called [18F]NIDF to take pictures of tau protein clumps in the brain, which are linked to Alzheimer's and other memory or movement disorders. It may help doctors see these changes more clearly.
This Phase 3 study uses a PET/CT scan to measure whether a brain protein called tau (and related disease patterns) builds up in different dementia conditions. The goal is to better match which disorders have which brain changes and how they progress.
This study uses a brain scan called PET to look at tau (a brain protein) and how it relates to thinking and memory. It may help researchers understand early brain changes, though it’s mainly for healthy people living near Columbia who have had an amyloid PET scan before.
This trial studies how tau (a protein linked to Alzheimer’s and related conditions) shows up on a special brain scan called tau PET. It also uses MRI and blood work to understand brain changes and who may be at risk, helping researchers improve future diagnosis.
This study uses a special PET scan to look at a brain protein called PDE4 in people with Alzheimer's disease or mild cognitive impairment. It may help researchers understand how this protein is involved in memory and thinking problems.
This study uses brain imaging and tests to better understand Parkinson's disease and related conditions. It aims to improve diagnosis by comparing scans across different groups of people.
Hear when a new Neurodegenerative Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.